Are patients with inflammatory bowel disease receiving optimal care?
about
Interventions and targets aimed at improving quality in inflammatory bowel disease ambulatory careAssessment of corticosteroid-related quality of care measures for ulcerative colitis and Crohn's disease in the United States: a claims data analysis.Guideline adherence and patient satisfaction in the treatment of inflammatory bowel disorders--an evaluation study.Indicators of suboptimal biologic therapy over time in patients with ulcerative colitis and Crohn's disease in the United StatesInflammatory bowel disease: Efficient remission maintenance is crucial for cost containment.Approaches to improve quality of care in inflammatory bowel diseases.Cancer surveillance strategies in ulcerative colitis: the need for modernization.Quality of care in Crohn's disease.Racial disparities in utilization of specialist care and medications in inflammatory bowel diseaseImpact of the Mobile HealthPROMISE Platform on the Quality of Care and Quality of Life in Patients With Inflammatory Bowel Disease: Study Protocol of a Pragmatic Randomized Controlled Trial.Quality of health care in the United States: implications for pediatric inflammatory bowel diseaseFramework for assessing quality of care for inflammatory bowel disease in Sweden.Management of Crohn's disease - are guidelines transferred to clinical practice?Corticosteroid Use and Complications in a US Inflammatory Bowel Disease Cohort.Challenges in designing a national surveillance program for inflammatory bowel disease in the United States.No differences in cancer screening rates in patients with rheumatoid arthritis compared to the general populationReview article: aminosalicylates for distal colitis.Review article: colorectal cancer surveillance in ulcerative colitis - what should we be doing?Inflammatory bowel disease: Pandora's box, present and future.Utilization of Preventive Measures for Glucocorticoid-Induced Osteoporosis among Veterans with Inflammatory Bowel Disease.Chemoprophylaxis of colorectal cancer in inflammatory bowel disease: current concepts.Rising Educators, Academicians, and Clinicians Helping Inflammatory Bowel Disease (REACH-IBD)-Promoting Improvement of Inflammatory Bowel Disease Education in the United States.Targeting nanomedicines in the treatment of Crohn's disease: focus on certolizumab pegol (CDP870).Quality of care for patients with inflammatory bowel disease in East China.Quality improvement in inflammatory bowel disease.Comparing guideline-based care quality for inflammatory bowel disease and rheumatoid arthritis patients within a medical home.Current use of immunosuppressive agents in inflammatory bowel disease patients in East China.NASPGHAN single-topic symposium: discovering the future of pediatric IBD care.Long-term direct costs before and after proctocolectomy for ulcerative colitis: a population-based study in Olmsted County, Minnesota.Quality of care in inflammatory bowel disease: a review and discussion.Care of inflammatory bowel disease patients in remission.ImproveCareNow: The development of a pediatric inflammatory bowel disease improvement network.Quality of care in inflammatory bowel disease.Development of process and outcome measures for improvement: lessons learned in a quality improvement collaborative for pediatric inflammatory bowel disease.Quality of care for gastrointestinal conditions: a primer for gastroenterologists.Topical therapies in inflammatory bowel disease.Colorectal cancer in inflammatory bowel disease: a shift in risk?Implementing quality measures for inflammatory bowel disease.Clinicians' adherence to international guidelines in the clinical care of adults with inflammatory bowel disease.Learning Health Systems as Facilitators of Precision Medicine.
P2860
Q26823569-FA3B35CE-3EE7-4802-A39F-E5CB1ACD1314Q31146183-5BD4DA2E-5DF5-44D6-AAC0-4530C2005499Q33403401-3E6F55EF-2455-4CAD-B9B3-8B29D99F74A6Q33584629-B4F17E0B-261D-4319-9D31-CE4CF79904B7Q33646458-9649B6C2-C05D-4CC8-A18B-742CF7C984ACQ33948298-C33647B0-B4B8-423D-A592-AE48FDB0AE78Q34150651-AEB1846A-EA34-4E9D-80E6-B422BB109930Q34508859-A56FFF22-47C2-47AD-87BC-14857E674CE0Q35205595-B413BF02-8AD8-4893-AFA3-DFA3A508D490Q35223262-D0D9B527-3375-4055-A6D7-6EAC781FC7A6Q35462049-37B39154-4C7A-46D8-AA72-08202AE19162Q35813211-7327BAF8-2027-4362-91B5-BB370632C5B9Q35926094-D45ADFE6-147A-4862-B7E1-817F7F0FE3DBQ36059784-B74B0122-18DA-4109-B87E-9539A036216EQ36174814-A2FC940E-75F2-45BA-90D1-2F745256FA79Q36291405-2EF12EBA-C9E2-4788-9E8F-8E2921D91626Q36589416-4E1F62AB-3B1F-4991-991A-FDDDF249CC90Q36589428-AE0A3571-D6A9-4F0D-B60D-65F04AB81692Q36631518-5F2BDAEC-8098-42D8-B2AB-72AB1DC601FBQ36844709-3B6CF0B1-7DE5-4B62-93B5-CBB717A7755BQ36849129-99F68946-4D0B-4F71-8C32-85AB9A527AB6Q36909512-9CABA67A-74F1-497D-9D6A-5DAE79B59E77Q36920423-97FE378C-DA75-4285-A331-30231E3FF76BQ37059857-FA13A1C7-808B-4957-BACC-4E24122DDC83Q37088512-DB203238-6D32-4C70-BE82-FC7428EDA7E4Q37146476-EF7D08A9-2BED-42EE-97F4-F3A9E49C4BDCQ37241970-6AE3D11B-AFCF-4782-B244-1006F3E1B8DFQ37467578-40E0B465-6A8F-406A-B2C4-43FFE3CE870AQ37470797-7E52DE20-8582-4755-87F9-D69DDEFFFDC2Q37538645-7DB8EDB4-8FF5-48B4-91F5-FE76310BA777Q37540172-4BA4DF09-97E5-4E5B-B5E7-637F15A16CFCQ37770101-BD773ABA-4376-4590-983A-5A8B7315C40BQ37809807-3BC20247-58F7-4928-B756-672329667B8CQ37860253-3D19A412-B0BA-454D-8FC7-856B0ECD1B92Q37897917-73F06607-4B8C-4BDF-A295-0CA2C6D59F86Q38050885-42EFFA2F-2D51-4426-B514-19A2491C31C3Q38195328-0C0DF09B-1CD0-49B7-8A4C-4D96C63369FEQ38374554-A4460C30-49E6-437F-9B60-59A596DF9D10Q38995675-3BFCD711-712A-4486-8B24-CF1783C0D399Q39041482-1608EE4B-599B-4488-8629-17D77255D3AE
P2860
Are patients with inflammatory bowel disease receiving optimal care?
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Are patients with inflammatory bowel disease receiving optimal care?
@ast
Are patients with inflammatory bowel disease receiving optimal care?
@en
type
label
Are patients with inflammatory bowel disease receiving optimal care?
@ast
Are patients with inflammatory bowel disease receiving optimal care?
@en
prefLabel
Are patients with inflammatory bowel disease receiving optimal care?
@ast
Are patients with inflammatory bowel disease receiving optimal care?
@en
P2093
P2860
P1476
Are patients with inflammatory bowel disease receiving optimal care?
@en
P2093
Jennifer J Telford
Lisa Strate
Peter A Banks
Rie Ookubo
Sarathchandra I Reddy
Sonia Friedman
P2860
P304
P356
10.1111/J.1572-0241.2005.40849.X
P407
P577
2005-06-01T00:00:00Z